Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

429.33 +1.57 (+0.37%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
From Thermo Fisher Scientific Inc.
Via Business Wire
This Market Is The Buying Opportunity Of A Lifetime
Via Benzinga
3 Profitable Stocks Skating on Thin Ice
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Is Thermo Fisher Scientific Gaining or Losing Market Support?
Via Benzinga
Earnings Scheduled For April 23, 2025
Via Benzinga
Earnings Preview For Thermo Fisher Scientific
Via Benzinga
Tariffs Bite Dan Loeb's Portfolio: Thermo Fisher Hit Hard, Discover Shines
Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%. 
Via Benzinga
Topics ETFs
Revvity (RVTY) Q1 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan
Thermo Fisher plans $2 billion U.S. investment amid tariff concerns, while analysts lower price targets despite reaffirming positive ratings. 
Via Benzinga
Topics World Trade
3 Healthcare Stocks with Mounting Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing
From Thermo Fisher Scientific Inc.
Via Business Wire
Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
TMO Q1 Earnings Call: Navigating Tariffs and Macro Uncertainty While Investing in Innovation
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 per... 
Via StockStory
Topics Economy World Trade
Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit and lower operating income. 
Via Benzinga
Topics World Trade
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
Thermo Fisher Reports Strong Q1 Earnings But Revises Full-Year Guidance In Light Of Trump Tariffs: Retail’s Pessimistic
The company now expects 2025 revenue to be in the range of $43.3 billion to $44.2 billion and adjusted EPS to be in the range of $21.76 to $22.84, compared with its previous forecast of $23.10 to... 
Via Stocktwits
Topics Earnings Government World Trade
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth. 
Via Benzinga
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q1
Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15... 
Via StockStory
Thermo Fisher Scientific Reports First Quarter 2025 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect. 
Via StockStory
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
S&P 500 Index Stocks To Watch: Google, Tesla, IBM, Intel, AT&T, Boeing, Chipotle
Via Talk Markets
Topics Stocks Stocks / Equities
Assessing Thermo Fisher Scientific: Insights From 9 Financial Analysts
Via Benzinga
Thermo Fisher Scientific Stock Up 1.3% After Key Signal
A significant trading signal occurred for shares of Thermo Fisher Scientific at $444.92, after which TMO rose up to 1.3%. 
Via Benzinga
A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack
Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Why Quality Investors Should Delve into THERMO FISHER SCIENTIFIC INC (NYSE:TMO) for Investment Opportunities.
A fundamental analysis of (NYSE:TMO): Is THERMO FISHER SCIENTIFIC INC (NYSE:TMO) suited for quality investing? 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 23, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy
Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.